Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns

benzinga.com/markets/equities/25/07/46257118/sonnet-biotherapeutics-drops-5-intraday-rebounds-14-after-hours-amid-delisting-concerns

Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) stock experienced a drop of 5.54% on Thursday, followed by a remarkable recovery of 14.29% in after-hours trading.
What Happened: Sonnet BioTherapeutics’ stock fell by 5% during regular trading hours on Thursday. The drop was attributed…

This story appeared on benzinga.com, 2025-07-04 03:42:07.
The Entire Business World on a Single Page. Free to Use →